Literature DB >> 3192440

Intramuscular injection techniques and the development of clostridial myositis or cellulitis in horses.

C M Brown1, J B Kaneene, R D Walker.   

Abstract

A survey of 584 veterinarians in equine practice was performed to determine their intramuscular injection techniques and the influence of those techniques on the development of clostridial myositis or cellulitis. Usable responses were obtained from 439 veterinarians (75.2%). Of these, 414 used a new needle and syringe for each injection, 241 swabbed the site with a cleansing/disinfectant agent, and 242 swabbed the top of multidose injection bottles with a similar solution. Only 2 clipped the hair at the injection site. Twenty eight of the respondents reported that at least 1 horse developed a clostridial infection at the injection site following 1 of their injections. None of the various injection techniques had a significant influence on the development of clostridial infection at the injection site.

Entities:  

Mesh:

Year:  1988        PMID: 3192440

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  3 in total

1.  Cecal perforation and communication with the retroperitoneal space after cecal impaction in a thoroughbred gelding.

Authors:  A Klohnen; D G Wilson; A J Cooley
Journal:  Can Vet J       Date:  1996-11       Impact factor: 1.008

2.  Acute myonecrosis in horse caused by Clostridium novyi type A.

Authors:  Luana D'avila Farias; Marcos Da Silva Azevedo; Maria Elisa Trost; Flávio Desessards De La Côrte; Luiz Francisco Irigoyen; Agueda Castagna de Vargas
Journal:  Braz J Microbiol       Date:  2014-04-08       Impact factor: 2.476

3.  An unusual necrotic myositis by Clostridium perfringens in a German Shepherd dog: A clinical report, bacteriological and molecular identification.

Authors:  Hamideh Salari Sedigh; Masoud Rajabioun; Jamshid Razmyar; Hossein Kazemi Mehrjerdi
Journal:  Vet Res Forum       Date:  2015-12-15       Impact factor: 1.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.